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Evidence for a causal link between sepsis
and long-term mortality: a systematic
review of epidemiologic studies
Manu Shankar-Hari1,2*†, Michael Ambler1†, Viyaasan Mahalingasivam1, Andrew Jones1,2, Kathryn Rowan3
and Gordon D. Rubenfeld4
Abstract
Background: In addition to acute hospital mortality, sepsis is associated with higher risk of death following hospital
discharge. We assessed the strength of epidemiological evidence supporting a causal link between sepsis and
mortality after hospital discharge by systematically evaluating the available literature for strength of association, bias,
and techniques to address confounding.
Methods: We searched Medline and Embase using the following ‘mp’ terms, MESH headings and combinations
thereof - sepsis, septic shock, septicemia, outcome. Studies published since 1992 where one-year post-acute
mortality in adult survivors of acute sepsis could be calculated were included. Two authors independently selected
studies and extracted data using predefined criteria and data extraction forms to assess risk of bias, confounding,
and causality. The difference in proportion between cumulative one-year mortality and acute mortality was defined
as post-acute mortality. Meta-analysis was done by sepsis definition categories with post-acute mortality as the
primary outcome.
Results: The literature search identified 11,156 records, of which 59 studies met our inclusion criteria and 43 studies
reported post-acute mortality. In patients who survived an index sepsis admission, the post-acute mortality was
16.1 % (95 % CI 14.1, 18.1 %) with significant heterogeneity (p < 0.001), on random effects meta-analysis. In studies
reporting non-sepsis control arm comparisons, sepsis was not consistently associated with a higher hazard ratio for
post-acute mortality. The additional hazard associated with sepsis was greatest when compared to the general
population. Older age, male sex, and presence of comorbidities were commonly reported independent predictors
of post-acute mortality in sepsis survivors, challenging the causality relationship. Sensitivity analyses for post-acute
mortality were consistent with primary analysis.
Conclusions: Epidemiologic criteria for a causal relationship between sepsis and post-acute mortality were not
consistently observed. Additional epidemiologic studies with recent patient level data that address the pre-illness
trajectory, confounding, and varying control groups are needed to estimate sepsis-attributable additional risk and
modifiable risk factors to design interventional trials.
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Background
Sepsis [1] is a global health care challenge [2]. Although
acute mortality from sepsis in adults is improving [3],
nearly a third of sepsis survivors are readmitted to hos-
pital within 30 days of discharge [4–6], have a three-fold
greater infection risk [7], and have persistently elevated
markers of inflammation [8]. In a systematic review that
included patients from both critical care (ICU) and non-
ICU settings, sepsis was associated with impaired quality
of life and increased long-term mortality [9].
However, outcomes after critical illness reflect a
complex interplay between patient demographics, co-
morbidity, risk factors for critical illness, treatments in
the ICU, and critical illness itself [10, 11]. Therefore, the
poor outcomes observed in survivors of sepsis may be
caused by sepsis or they may simply reflect events that
would have occurred in these patients had they not be-
come septic or had they been admitted to the hospital
for reasons other than sepsis [10–14].
It is an important question, as a more comprehensive
understanding of the causes and mechanisms of the
post-ICU syndrome might inform more effective inter-
ventions. If post-sepsis long-term outcomes are primarily
driven by the trajectory of pre-morbid conditions, then
interventions targeted at complications attributed to
critical illness may not be effective. Approaches to this
question might take many forms including an analysis of
biologic plausibility from animal studies of sepsis.
Randomized trials that involve inducing sepsis are, of
course, impossible in humans. Therefore we focused on
observational studies of sepsis or cohorts derived from
randomized trials. This study aims to systematically re-
view the existing epidemiologic literature to specifically
assess how a causal link between sepsis and mortality
after hospital discharge is addressed, by evaluating the
available literature for strength of association, impact of
bias, and techniques to address confounding, to deter-
mine if increased long-term mortality reported after sep-
sis is caused by sepsis.
Methods
Approach
The standards for causal inference from observed associ-
ations in epidemiology are well-established [15–17].
These include associations that are strong and independ-
ent of bias or confounding, consistent across studies,
specific to the exposure, demonstrate an increasing risk
of the outcome with higher levels of exposure (dose-
response), and are biologically plausible [14, 18]. We
evaluated the extent to which studies fulfilled these
criteria using the following framework. First, we sepa-
rated the cumulative long-term mortality in to its
components of acute and post-acute mortality. The causal
effects of sepsis on acute mortality are well-described. As
cumulative long-term mortality incorporates acute mor-
tality, an evaluation of the long-term effects of sepsis must
isolate its unique effects on post-acute mortality from its
effects on acute mortality. Second, the study design and
analytic approach to confounding and bias were mea-
sured. This included whether patients were lost to follow
up and the use of restriction, matching, stratification, and
regression. We evaluated which variables the authors used
as potential confounders. Third, as design and analytic ap-
proaches to confounding may be insufficient, we looked
for the type and number of control populations included
to minimize bias in the comparison and to clarify whether
the outcomes following sepsis exposure were specific or
merely a reflection of survival from critical illness. Finally,
we assessed whether studies evaluated a dose-response re-
lationship between sepsis and post-acute mortality, with
the hypothesis that more severe sepsis, for example, septic
shock, should be associated with higher post-acute mor-
tality within a study and there should be an inverse rela-
tionship between acute mortality and post-acute mortality
between studies.
Information sources
A systematic review of non-randomized and random-
ized clinical studies indexed within the Medline and
the Embase databases were performed using the Ovid
platform. Search terms included the following ‘mp’
terms, medical subject headings (MESH) and combi-
nations thereof - sepsis, septic shock, septicemia, out-
come, quality of life, cohort studies, and randomized
controlled trials. The following limits were applied:
humans, English language and publications since
1992. Subject headings were exploded and mapped to
the appropriate MeSH. The search was restricted to
English language articles published in or after 1992,
when the first consensus definitions were introduced
[19]. The full electronic search strategy for Medline is
presented in electronic supplementary material (Additional
file 1: Table S1).
Eligibility criteria for full text review
We included studies in adult patients reporting an epi-
sode of sepsis defined using either the 1992 [19] or the
2003 [20] consensus definitions with the following
mandatory criteria: (1) the studies must report all-cause
one-year or longer mortality and (2) must report the
consensus definition components that could be assessed.
In our search strategy we included studies reporting
quality of life or cognitive outcomes on post-discharge
follow up and initial full text review to identify studies
that reported long-term mortality as one of the second-
ary outcomes. To generate a more homogenous sepsis
population, we excluded studies exclusively reporting
pediatric patients, patients with retroviral disease or
Shankar-Hari et al. Critical Care  (2016) 20:101 Page 2 of 13
cancer, other specific cohorts such as immune-compro-
mised patients, and obstetric cohorts.
Study selection for evidence synthesis
Two authors (MA and VM), using predefined inclusion
criteria based on review of the titles and abstracts, per-
formed independent assessment of studies identified
within the literature search. Consensus was reached on
the inclusion of studies after independent review of the
studies (by MSH) and by mutual agreement of the re-
viewers. In order to avoid including the duplicate data
where multiple articles were found that presented data
from the same cohort of patients, the most relevant art-
icle was chosen by consensus (MA and MSH). To obtain
the full text of the included studies, the authors were
contacted if it was not possible to obtain from existing
databases (n = 1) [21].
Data collection process and items
Two authors (MA and MSH) extracted data from the
included studies and issues of uncertainty were resolved
by consensus. From each of the included studies we
extracted the following data to explore generic and
study-specific quality checklists. The generic quality
checklist included variables to inform a modified
Newcastle-Ottawa score (NOS): study years (recruit-
ment), country, single or multi-center, study design,
number of patients, duration of follow up, evidence of
selection bias at enrollment, proportion of patients lost
during follow up, loss during follow up explained and
key outcomes reported (Additional file 1: Table S2). The
study-specific quality checklist included variables to as-
sess (1) baseline risk of death (age, sex, comorbidity
score or index, or pre-sepsis functional status, or comor-
bidity type); (2) acute illness risk of death (severity of ill-
ness score or a surrogate); (3) description of sepsis
(definition, sepsis categories); (4) approach to bias; (5)
approach to confounding; (6) separation of mortality
endpoints to address post-acute mortality; and (7) use of
non-sepsis control groups for comparisons.
Outcome definitions
In this study, acute mortality refers to hospital mortality
during the index sepsis admission episode (28-day or ICU
mortality was used when hospital mortality was not re-
ported). Cumulative one-year mortality refers to the total
reported mortality at one year. The primary study outcome
was post-acute mortality, which we defined as the differ-
ence between cumulative and acute mortality (Fig. 1).
Description of bias assessment
In addition to the bias assessments described in the
generic quality checklist (Additional file 1: Table S2),
descriptions of setting and data source were used to
assess the accuracy of exposure (sepsis) and informa-
tion bias. To assess the risk of bias from loss to fol-
low up, we collected data on completeness of follow
up and how the primary outcome of interest (post-
acute mortality) was ascertained. We coded the risk
of ascertainment bias as low and follow up as
complete, if the studies used either national/regional
databases or by direct contact with the patient/family.
Description of confounding assessment
The study design and analytic methods used to address
confounding in studies were categorized as restriction,
matching, stratification, and regression. Restriction as a
method to reduce confounding was defined either as use
of specific sepsis/infection populations or as use of any
additional criteria to specifically influence the relation-
ship between sepsis and post-acute mortality (for ex-
ample, when only patients with no comorbidities were
included in an analysis). Matching was coded as yes if
performed either at study design or during analysis.
Stratified analysis was coded as yes if the studies report
mortality stratified on predictor variables. Any use of
multivariate regression to examine mortality or survival
time was coded. We evaluated regression models separ-
ately depending on whether they used post-acute, or cu-
mulative mortality as the outcome variable. The sepsis
case definition was categorized as either consensus
based, or modified from consensus definition, or other.
Statistics
We calculated the difference in proportion between cu-
mulative one-year mortality and acute mortality. This
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Acute mortality Cumulative mortality
X%
Y%
Outcome =  
cumulative  
mortality
Outcome =  
post-acute  
mortality  
(Y% - X%)
Fig. 1 Approach to the study question. Post-acute mortality was
estimated as the difference between one-year mortality and
acute mortality, to address the study questions as described
(see “Methods”, “Approach”). We assessed whether the studies
used cumulative mortality or post-acute mortality in regression
models. This was done to identify risk factors that are associated
with post-acute mortality, which will help future researchers delineate
modifiable risk factors. This approach helps to generate a summary
estimate of post-acute mortality and also explores the relationship
between acute mortality and post-acute mortality at cohort level
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post-acute mortality rate and the cohort size were used
to estimate the number of post-acute deaths. Random
effects meta-analysis was done to generate summary
post-acute mortality estimates. A contour-enhanced fun-
nel (confunnel) plot was used to assess publication bias
[22]. The distributions of statistical significance in the
confunnel plot are derived from the Wald statistic for
the effect estimate of each study, with asymmetry imply-
ing potential publication bias. Egger’s test for small-
study effects was done, which regress the standard nor-
mal deviate of the study effect estimate against its stand-
ard error. The dose-response effect refers to an increase
in the risk of adverse outcomes with increase in severity
of sepsis. If a cohort has high acute mortality, the survi-
vors may or may not have higher post-acute mortality.
An aaplot was used to estimate this dose-response rela-
tionship between acute mortality and post-acute mortal-
ity [23]. Finally, we performed two sensitivity analyses
using random effects meta-analysis of post-acute mortal-
ity by including only studies with an NOS score ≥5, as a
surrogate for high study quality and by the acute-
mortality time point reported. All analyses were done
using Stata/MP 13.1 StataCorp College Station, TX,
USA.
Results
Study selection
The literature search identified 11,156 records. Follow-
ing exclusion of duplicates, and title screening, there
were 5,109 abstracts to screen. Following abstract
screening, 75 articles met the criteria for full text evalu-
ation. We excluded a further 26 articles reporting quality
of life and/or follow-up mortality for less than one year
(n = 24) and 2 studies using data from the same cohort.
Ten additional studies were identified from the reference
scan of the 49 studies that were included from full text
review. Thus, 59 studies were included for qualitative re-
view. Amongst these two studies did not report mortal-
ity data [24, 25], post-acute mortality could not be
estimated from three further studies [26–28], and one
study did not report the duration of follow up [21].
Thus, 53 studies were included for quantitative review,
of which 43 studies contained sufficient data to estimate
one-year post-acute mortality. Ten studies that report
2-year to 10-year mortality were excluded from quan-
titative review [11, 29–33], but were included for infor-
mation in answering other questions. Only 16 studies
included control arms so that the causal effects of sepsis
on post-acute mortality could be assessed [7, 25, 30–43].
(Fig. 2; Table 1; Additional file 1: Table S3-S4).
Post-acute mortality
The mean (95 % CI) one-year post-acute mortality
estimated from 43 studies using random effects
meta-analysis was 16.1 % (14.1, 18.1 %) with signifi-
cant heterogeneity (I2 = 98.9 %; p < 0.001) (Fig. 3).
The one-sided confunnel plot shows asymmetry,
which could be interpreted either as implying poten-
tial publication bias or as consistent results across
studies supporting causality (Fig. 4a). There were no
statistically significant small-study effects (Egger’s
test p = 0.883; Additional file 1: Table S5). Studies
that included patients with higher mortality in acute
sepsis did not demonstrate lower mortality in the
post-acute period from a shift in the timing of death
(Fig. 4b). Most studies report patient cohorts prior to
2005 (Fig. 3). In sensitivity analyses, the post-acute mortal-
ity (reported as mean (95 % CI)) were consistent with
primary analysis (in high quality studies (n = 33),
mean =16.3 % (13.6–19.0 %); I2 = 98.6 %; p < 0.001, in
studies reporting hospital mortality (n = 23), mean = 16.6 %
(13.5–19.6 %); I2 = 99.0 %; p < 0.001, and in studies report-
ing 28- or 30-day mortality (n = 20), mean = 15.8 %
(14.1–17.4 %); I2 = 93.3 %; p < 0.001).
Bias assessment
The risk of bias in the included studies was variable,
with asymmetric NOS distribution (Table 1; Additional
file 1: Table S3; Additional file 1: Figure S1). Consensus
criteria were the most commonly used case definitions.
Case identification was often retrospective, thus in these
cases there was potential for information bias secondary
to accuracy of exposure. RCTs are likely to have the least
risk of information/exposure ascertainment bias. Na-
tional or regional databases (with or without contact
with the family) were used by most studies to ascertain
post-acute mortality, implying this would not be a major
contributor to bias. Overall risk of bias and quality
assessed using modified NOS score variables highlighted
10 studies with high risk of bias/poor quality (NOS score
<5; Additional file 1: Figure S1 and Additional file 1:
Table S3).
Confounding assessment
Confounding in the relationship between sepsis and
post-acute mortality potentially occurs when risk factors
or confounding variables are distributed unequally be-
tween survivors and non-survivors. Studies without
control groups cannot answer the causal question, but
inform the reasons for the variability observed in
studies.
The definitions for patient inclusion criteria in the
studies could be categorized into five groups (pneumo-
nia, consensus sepsis based definitions and modifications
thereof, consensus sepsis definitions but pathogen iden-
tification mandated in the inclusion criteria, claims/ICD
codes for sepsis, and peritonitis cohorts (Table 1). There
was significant heterogeneity in post-acute mortality
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within these categories (p < 0.001). In five studies re-
stricted to patients with septic shock, the post-acute
mortality varied between 7.0 % and 21.1 % [44–48].
Similar variations in the relationship between sepsis and
post-acute mortality were observed in studies limited to
elderly populations [11, 24, 25, 38, 40, 41, 49], a
southern US cohort aged 45 years or older [50], male
patients [39], obese patients [51], and in a separate
analysis restricted to a previously healthy population
[37]. This implies, the determinants of the relationship
between sepsis and post-acute mortality are unclear,
thus, key restriction variables need to be ascertained.
11156 records identified 
through database searching 37 additional records from 
other sources#
5109 records after screening title and excluding duplicates
5034 records excluded after abstract
75 of full text articles assessed for eligibility
26 of full text articles excluded
(N=24 QOL report and/or <1-year mortality
and N=2 Duplication of cohorts) 
N=53 included for quantitative review
N=2 No mortality data
N=3 Post a/c mortality not reported 
N=1 Duration of follow-up not stated
N=10 studies only report 2-10 year post 
acute mortality
N=43 with one-year post acute 
mortality 
N=16 report control arm to assess whether sepsis is an 
independent predictor for post-acute mortality risk
N=10 additional studies from reference lists 
of included studies
N=59 for qualitative review 
Id
en
tif
ic
at
io
n
S
cr
ee
ni
ng
E
lig
ib
ili
ty
In
cl
ud
ed
Fig. 2 Flow diagram showing the literature search and results. #Non-duplicate articles were identified from the references list of two review
articles [9, 10]. QOL quality of life. A/c refers to acute
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Studies reporting controls
There were 16 studies that included control groups to
evaluate the effects of sepsis on post-acute mortality; 7
studies used the general population [30, 33, 37, 40–43],
13 used hospitalized controls (ICU, infected patients,
and non-infected patients) [7, 25, 30–32, 34–41], and 4
studies used both [30, 37, 40, 41]. From these studies we
evaluated whether sepsis is an independent risk factor
for post-acute deaths and what other independent pre-
dictor variables were associated with post-acute mortal-
ity in sepsis patients (Additional file 1: Table S3, S4 and
S6; Fig. 5a-d)
Studies reporting general population controls
In age- and sex-matched life-table data comparisons,
post-acute mortality in pneumonia cohorts was two
[43] to six times [33] higher than in the general
population. Interestingly, when the age-, sex- and
race-matched comparisons were stratified by comor-
bid status, the significant post-acute mortality risk
Table 1 Assessment of study quality, risk of bias, and
confounding
Methodological assessment summary (N=59 studies) %*
1. Exposure definition (sepsis)
i) Consensus [7, 8, 28–32, 35, 37, 39, 40,
44, 45, 47–50, 63–74]
49 %
ii) Claims/ICD codes [11, 24–26, 38, 41,
58, 75–77]
14 %
iii) Pathogen-plus (either positive blood
culture or pathogen specified)
[27, 34, 36, 46, 53, 78–81]
20 %
iv) Pneumonia [33, 40, 42, 43, 52, 82–85] 15 %
v) Peritonitis [21, 51, 86] 5 %
2. Ascertainment of exposure
i) Claims/ICD codes data 13 %
ii) Randomized controlled trial cohorts
[44, 45, 63, 66, 69, 70]
10 %
iii) Non-interventional study cohorts 75 %
3. Selection of the control cohort
i) Drawn from ICU patients without sepsis
a. Matched [35] 2 %
b. Not matched [7, 25, 30–32, 37, 41] 12 %
ii) Drawn from hospitalized infected
patients (not ICU)
a. Matched
b. Not matched [30, 41] 3 %
iii) Drawn from hospitalized non-infected
patients (not ICU)
a. Matched [36] 2 %
b. Not matched [30, 34, 38–41] 10 %
iv) Population controls
a. Matched [30, 33, 37, 41–43] 10 %
b. Not matched [40, 41] 3 %
v) No control cohorts/no controls for
mortality comparison
73 %
4. Comparability of cohorts on the basis of
design or analysis
i) Regression models to adjust for confounders
a. Regression models in studies reporting
control population
- Post-acute mortality [7, 25, 30, 33–37,
39, 42]
16 %
- Cumulative mortality
- Stratified analysis for post-acute
mortality [32, 40, 42, 43]
5 %
- Non-mortality outcome models [31, 38, 41] 5 %
b. Regression models using in studies with
no controls
- Post-acute mortality 22 %
- Cumulative mortality 20 %
- No mortality model 31 %
Table 1 Assessment of study quality, risk of bias, and
confounding (Continued)
ii) Studies reporting sepsis dose-response
[39, 46, 49, 52, 53]
9 %
5. Assessment of post-acute mortality
i) Record linkage with national or regional
databases or outcome assessed by contact
with patient or relatives
90 %
ii) No description 10 %
6. Adequacy of follow up
i) Complete follow up, all participants
accounted for
22 %
ii) Loss to follow up unlikely to introduce
bias (<20 % loss, or >20 % but those lost
described and unlikely to be different from
those followed)
61 %
iii) Follow up <80 % and no description of
those lost
3 %
iv) No statement 14 %
7. Report both acute and post-acute mortality
(or that information can be determined from
the reported data)
i) At one year 72.9 %
ii) Between 2 and 10 years [11, 29–32] 8.5 %
iii) No mortality data/post-acute mortality
not estimable/follow-up time unclear
[21, 24–28]
10.2 %
*Reported proportions (%) corrected to nearest whole number. Study
quality and risk of bias was assessed on selection, comparability, and
reported outcomes using the Newcastle Ottawa Score checklist (Additional
file 1: Table S2). Sepsis case definition evaluates the representativeness of
the cohort and ascertainment of exposure by assessing concordance with
the sepsis definitions to the definition of Bone et al. [19] or Levy et al.
[20]. Studies reporting data from randomized controlled trials (RCTs) are
likely to have a lower score as non-sepsis controls are not evaluated
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NOTE: Weights are from random effects analysis
.
.
.
.
.
Overall  (I−squared = 98.9%, p = 0.000)
Laterre PF et al (66)
Yealy DM et al (43)
Braun L et al (75)
Perl TM et al (70)
Wang HE et al (49)
Weycker D et al (77)
Reade MC et al (85)
Johnstone J et al (51)
Subtotal  (I−squared = 88.6%, p = 0.000)
Subtotal  (I−squared = 99.8%, p = 0.000)
Fätkenheuer G et al (79)
Lee H et al (67)
Forceville X et al (44)
Jacobsson G et al (52)
Subtotal  (I−squared = 95.7%, p = 0.000)
Consensus
Sasse KC et al (80)
Carlsen S et al (47)
Yende S et al (9)
Subtotal  (I−squared = 96.0%, p = 0.000)
Drewry AM et al (78)
Claims/ICD codes
Ou SY et al (76)
Study
Yende S et al (39)
Liu V et al (57)
Adamuz J et al (82)
Lopes JA et al (68)
Prescott HC et al (37)
Linder A et al (36)
Quartin AA et al (38)
Laupland KB et al (45)
Vasile VC et al (74)
Shapiro NI et al (73)
Subtotal  (I−squared = 99.0%, p = 0.000)
Puskarich M et al (71)
Carl DE et al (64)
Peritonitis
Bates DW et al (33)
Hynninen M et al (86)
Opal SM et al (69)
Angus DC et al (63)
Pneumonia
Regazzoni CJ et al (48)
Hsu JL et al (84)
Seidelin JB et al (72)
Leibovici L et al (35)
Brancati FL et al (83)
Utzolino S et al (50)
Pathogen plus
Davidson TA et al (34)
Karlsson S et al (65)
Yende S et al (40)
Poulsen JB et al (46)
2002−2004
2008−2013
1995−1998
1986−1990
2003−2007
1991−2000
2001−2003
2000−2002
1997−2000
1996−1999
2002−2004
2003−2005
1987−1991
2007
2001−2003
2010−2012
2000−2010
Recruitment Year
1997−1998
2010
2007−2011
2002−2007
1998−2005
2000−2004
1983−1986
1999−2002
2001−2006
2000−2001
2004−2007
2000−2004
1988−1990
2001−2003
2006−2010
1998−2000
2002−2003
2003−2007
NR
1988−1992
1988−1989
NR
1994−1996
2004−2005
2002−2006
2006−2007
16.12 (14.13, 18.10)
16.38 (15.13, 17.63)
21.10 (18.92, 23.29)
15.49 (14.16, 16.82)
14.00 (7.20, 20.80)
14.02 (11.84, 16.21)
30.20 (29.48, 30.91)
17.32 (15.73, 18.90)
16.08 (14.84, 17.31)
15.18 (10.94, 19.43)
23.05 (14.09, 32.00)
12.66 (8.36, 16.97)
7.75 (5.88, 9.62)
20.69 (5.95, 35.43)
12.00 (2.99, 21.01)
9.95 (−2.54, 22.45)
20.26 (13.89, 26.63)
18.94 (12.26, 25.62)
16.28 (14.61, 17.94)
15.49 (13.14, 17.83)
12.24 (8.73, 15.75)
12.90 (12.62, 13.18)
Post−acute Mort (95% CI) Weight
8.49 (3.18, 13.80)
24.80 (23.73, 25.86)
6.55 (5.25, 7.84)
10.80 (7.85, 13.75)
31.95 (29.58, 34.31)
13.59 (11.50, 15.69)
23.99 (21.83, 26.14)
10.76 (6.92, 14.59)
7.02 (5.37, 8.66)
16.12 (14.82, 17.41)
15.00 (9.69, 20.32)
21.05 (16.32, 25.79)
17.69 (11.52, 23.86)
15.38 (11.97, 18.80)
3.68 (0.79, 6.57)
15.96 (14.34, 17.58)
17.57 (15.76, 19.39)
29.17 (16.31, 42.03)
20.70 (20.36, 21.04)
25.40 (14.65, 36.15)
22.00 (20.18, 23.82)
21.28 (14.52, 28.03)
16.43 (12.14, 20.73)
3.36 (0.12, 6.60)
12.55 (9.56, 15.55)
22.30 (21.34, 23.26)
6.98 (3.17, 10.78)
100.00
2.56
2.51
2.56
1.99
2.51
2.58
2.55
2.57
15.74
12.80
2.31
2.53
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seen in young patients with pneumonia remained in
those with comorbidity and was no longer
statistically significant in those without comorbidi-
ties, implying that the crude effects were likely
attributable to age and comorbidity [42]. Sepsis co-
horts requiring ICU care also have two- to five-fold
higher risk of post-acute death than the general
population [30, 36, 37, 39, 41].
0
2
4
6
8
S
ta
nd
ar
d 
er
ro
r
−20 −10 0 10 20 30
Post−acute mortality (%)
Studies
1%
5%
10%
Confunnel plot (one sided)
5
10
15
20
25
30
P
os
t−
ac
ut
e 
m
or
ta
lit
y 
(%
)
0 20 40 60
Acute mortality (%)
n = 43    RMSE =  6.787376
p100 = 17.508 − .04311 Acute100   R 2 = 0.9%
Assessment of relationship between acute mortality and post−acute mortality
a
b
Fig. 4 a One-sided contour-enhanced funnel (confunnel) plot. The figure either implies potential publication bias or consistency in results (imply-
ing causality) across the published studies identified by this systematic review. The confunnel plot adds contours of statistical significance to the
standard funnel plot and assesses whether the areas where studies are potentially missing correspond to areas of low statistical significance, the as-
sumption being that studies that do not attain statistical significance boundaries are less likely to be published. b Post-acute mortality versus acute
mortality with linear fit superimposed and assessed between study dose-response effects. The equation, R-square statistics of the fit, the sample size
and root mean square standard error (RMSE)(s) are also shown (referred to as aaplot and designed by Nicholas J. Cox)
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Studies reporting hospital controls
The unadjusted post-acute mortality for severe sepsis
when compared to hospitalized controls was no longer
significantly different when adjusted for confounders
such as age and comorbidities [30]. Amongst eleven
studies with non-sepsis controls, six studies include sep-
sis as an exposure within regression models to evaluate
the independent effect of sepsis on post-acute mortality.
Sepsis was an independent predictor in four studies
[25, 35, 37, 39]. Sepsis ceases to be an independent
predictor of post-acute mortality as the comparator
group severity of illness increases from hospitalized
non-infected to ICU non-sepsis (Fig. 5b-d) [7, 25, 30–41].
The common non-sepsis predictor variables in the regres-
sion models from these eleven studies were age (n = 8)
and comorbidity (n = 8).
Dose-response effect of sepsis on post-acute mortality
We observed an inconsistent sepsis–post-acute mortality
dose-response effect in studies. The post-acute risk of
death increases with worsening pneumonia [52] and
with sepsis severity [39, 49]. Unexpectedly, septic shock
was associated with a significant reduction in post-acute
hazard ratio (0.77 (0.68–0.86); p < 0.001) [46], whilst sep-
sis was associated with higher post-acute mortality than
severe sepsis (17.8 % vs. 14.0 %) [53] again highlighting
the importance of baseline-risk factors on post-acute
deaths amongst sepsis survivors.
Discussion
The main finding of this systematic review is that an
additional 16.1 % of deaths among patients admitted
with acute sepsis occur between hospital discharge and
one year in patients who survive an index admission
with sepsis (post-acute mortality). Post-acute mortality
was identified in studies using national databases and
loss to follow up at one year was low, implying a lower
risk of ascertainment and information bias. In studies
that assess whether sepsis is an independent predictor of
post-acute mortality, the magnitude of additional risk at-
tributable to sepsis was inconsistent. Even in studies
with low risk of bias, the limited reporting of sepsis sub-
groups precludes generating summary assessments.
Common predictors of post-acute mortality were age
and comorbidity. Studies that assessed the effect of sep-
sis on post-acute mortality with multiple control popula-
tions highlight the potential for confounding in the
studies that either do not use controls or report un-
adjusted data for the relationship between sepsis and
post-acute mortality (Fig. 5). In studies that report
control populations, comorbidity, male sex, baseline
functional status and acute severity of illness were
highlighted as potential factors influencing the relation-
ship between sepsis and post-acute mortality.
The key strengths of our systematic review include
limiting the study population to adult sepsis cohorts
and limiting the outcome to mortality. We separated
cumulative long-term mortality into its two compo-
nents, which address importantly different hypotheses.
A customized NOS checklist enabled us to assess
potential for bias in the ascertainment of exposure
and outcome in addition to how included studies ad-
dressed confounding. We also used accepted criteria
to assess causality in these studies [14, 18].
There are limitations to this systematic review. To ad-
dress our study question, we defined long-term outcome
as one-year mortality and excluded studies reporting
shorter post-discharge outcomes. As this was a system-
atic review we were limited to the available studies,
many of which included patient cohorts studied prior to
2005. It is possible that recent trends in acute mortality
from sepsis might mean that appropriately performed
studies would uncover a persuasive causal link between
sepsis and post-acute mortality. This could occur if pa-
tients who would have died from sepsis in past years
now survive to hospital discharge and now succumb to
sepsis-specific morbidity in the post-acute phase. A simi-
lar issue limits the analysis of the dose-response effect of
sepsis on post-acute mortality. If more severe forms of
sepsis increase acute mortality, any effect on post-acute
mortality will not be seen. The studies had limited access
to comorbidity and many factors were not accounted
for, including the trajectory of prior hospitalizations,
nutritional status, discharge location, and family support.
However, given the direction of the effects of confound-
ing it is likely that more accurate recording of
confounders would further blunt any independent asso-
ciations between sepsis and post-acute mortality. There
is related literature outside the remit of this systematic
review, reporting the independent impact of acute
respiratory distress syndrome (ARDS) on long-term
outcomes [54, 55]. However, pneumonia and extra-
pulmonary sepsis account for nearly 75 % of the ARDS
cohort in the recently published LUNG-SAFE observa-
tional study [56], implying potential utility of our review
to this population. Finally, although our analysis argues
against outlier effects from small studies, we cannot ex-
clude the possibility that larger cohorts could identify a
smaller effect of sepsis on post-acute mortality.
A systematic review of long-term outcomes from sep-
sis has been publised previously [9], and whilst there are
similarities to our review there are a number of key dif-
ferences. First, we defined and evaluated post-acute mor-
tality at one year. Second, we focused on evaluating the
potential causality relationship between sepsis and post-
acute mortality. Third, we specifically assessed risk of
bias in studies, beyond generic quality checklists. Fourth,
to answer the causality question, we identified key
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confounders, risk of confounding, and methods used to
address confounding in studies. Fifth, by fixing the out-
come of interest as one-year post-acute mortality, we
were able to perform random effects meta-analysis and
explore publication bias whilst taking study quality into
account [22].
Our systematic review highlights the need for a more
coherent approach to understand the true magnitude of
the additional, independent, and potentially modifiable
impact of sepsis on post-acute mortality. First, the base-
line risk variables could be categorized into fixed risk
factors (e.g., age, sex, and race), and modifiable risk fac-
tors (e.g., comorbidities). Different comorbidities may
have a different impact on outcomes and comorbidities
themselves may progress following acute insults [10, 13].
The health status trajectory prior to the acute illness tra-
jectory is an important determinant that needs to be
accounted for in future studies [24]. Thus young, previously
healthy population without comorbidities is an important
subset to study in addition to the more common older
population with pre-existing comorbidities. Second, index
sepsis admission is often followed by readmission(s), which
may impact on one-year survival [57]. This readmission is
often related to infection [4, 7, 58], which highlights the
need for basic science and translational research into the
contributing mechanisms. Third, the duration of modifiable
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Fig. 5 Additional post-acute hazard with sepsis. To illustrate the differences in additional hazard with sepsis, all four sub-graphs were generated
with the same scale on the x axis. Dashed line at hazard ratio 1 is the reference line; shaded area shows the range between 0 and 1. If the same study
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higher risk needs to be explored. There may be a thera-
peutic window to potentially deliver enhanced post-acute
care and a novel window for trials of new interventions.
Frailty occurs in patients with sepsis and in sepsis survivors
[24, 59, 60]. Therefore, future studies should aim to docu-
ment the influence of the pre-illness trajectory and post-
acute survival time on the progression of underlying co-
morbidities and frailty [10, 13]. Researchers need to con-
sider whether cause-specific mortality may add useful
information in long-term outcome studies of acute illnesses
like sepsis. These approaches that we propose for research
into sepsis-related post-acute mortality have similarities
with the post-intensive care syndrome stakeholder priorities
[61]. Finally, sepsis and septic shock has been recently rede-
fined [1, 62], which also prompts reassessment of the post-
acute mortality and mobidity epidemiology using more re-
cent patient cohorts.
Conclusions
The available literature is of insufficient quality to sus-
tain the hypothesis that sepsis exerts an independent
and potentially causal effect on post-acute mortality. In-
ferences about a causal link between sepsis and post-
acute mortality is based on a few studies that have inad-
equately adjusted for confounders in the relationship
between acute illness and longer-term survival, such as
age, effect of comorbidity, pre-acute illness trajectory,
and functional status at hospital discharge.
Key messages
 Post-acute mortality in sepsis survivors is common;
however, causality and the magnitude of this
relationship is uncertain
 Acute mortality from sepsis has improved with time.
Most studies in this systematic review report patient
cohorts recruited before the year 2005 and report
additional one-year risk of death following sepsis. Only
a minority of included studies report control cohorts
and explicitly assess sepsis-specific additional risk
 Our systematic review thus highlights the need for
well-conducted studies using more recent datasets to
identify the independent (and modifiable) predictors
of post-acute mortality in sepsis survivors
Additional file
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